CENTER FOR AIDS RESEARCH
艾滋病研究中心
基本信息
- 批准号:8172317
- 负责人:
- 金额:$ 13.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-05-01 至 2011-04-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAcquired Immunodeficiency SyndromeBehavioral ResearchBiological AssayCanadaClinicalClinical ResearchClinical VirologyCollaborationsComputer Retrieval of Information on Scientific Projects DatabaseDrug usageEquipmentFacultyFlow CytometryFundingFutureGene ExpressionGermanyGrantGrowthHIVHIV InfectionsHome environmentHousingHuman immunodeficiency virus testImmunityImmunologyImmunophenotypingIndiaInfectionInstitutionInternationalMethodsPathogenesisPreventionQuebecRecruitment ActivityResearchResearch PersonnelResourcesScienceScientistSecondary PreventionServicesSourceStaining methodStainsTrainingTranslational ResearchUnited States National Institutes of HealthUniversitiesVaccinesViral Load resultcytokinedrug discoveryinterestmemberpre-clinicalvaccine developmentvirology
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The Center for AIDS Research (CFAR) at Emory has the primary purpose of facilitating conduct of scientifically rigorous basic, clinical, translational, and behavioral research in HIV/AIDS and to connect HIV/AIDS researchers within and across scientific fields. This continues to be accomplished through five HIV/AIDS research domains. These include Vaccine Development and Testing, HIV Pathogenesis and Drug Discovery, Clinical and Translational Research, Prevention Science, and, as an overarching domain, International Studies. Our objective was to facilitate the growth of NIHfunded research in the primary and secondary prevention of HIV and its aftermath.
Of particular interest, the Immunology Core, housed at the Vaccine Center at Yerkes, successfully provided training in basic methods in immunophenotyping by flow cytometry, in ELISpot assays, and in intracellular cytokine staining assays to scientists from Canada (F. Fladin, Universite de Quebec, HIV infection in drug use), Germany (B. Bengsch, University of Germany, HCV/HIV co-infection), and India (V. Ramachandran and K. Murugarel, HIV infection and mucosla immunity). These positive interactions continue to produce future opportunities for collaboration between Emory and investigators from the trainees' home labs.
The CFAR Pre-Clinical Virology Core, also housed at the Vaccine Center at Yerkes, provides valuable assay services to investigators, both within Emory and at other facilities. In addition to the viral load assays it has long performed, this unit now offers an array of gene expression assays, developed by this Core in the past year. Finally, the Virology Core provides training to those investigators who want to perform their own assays, and also makes its highly technical assay equipment available to these investigators.
Through the strategic use of GRA funds, the CFAR was able to retain key faculty members, recruit junior faculty, and provide essential equipment to a number of Cores, including the Immunology, Virology and Drug Discovery, and Clinical Research Cores.
该子项目是利用该技术的众多研究子项目之一
资源由 NIH/NCRR 资助的中心拨款提供。子项目和
研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金,
因此可以在其他 CRISP 条目中表示。列出的机构是
中心,不一定是研究者的机构。
埃默里大学艾滋病研究中心 (CFAR) 的主要目的是促进在艾滋病毒/艾滋病方面进行科学严谨的基础、临床、转化和行为研究,并将科学领域内和跨科学领域的艾滋病毒/艾滋病研究人员联系起来。 这继续通过五个艾滋病毒/艾滋病研究领域来完成。 这些包括疫苗开发和测试、艾滋病毒发病机制和药物发现、临床和转化研究、预防科学,以及作为一个总体领域的国际研究。我们的目标是促进 NIH 资助的艾滋病毒一级和二级预防及其后果研究的发展。
特别令人感兴趣的是,位于 Yerkes 疫苗中心的免疫学核心成功地为来自加拿大的科学家提供了流式细胞术免疫表型分型、ELISpot 测定和细胞内细胞因子染色测定基本方法的培训(F. Fladin,魁北克大学) ,吸毒中的 HIV 感染)、德国(B. Bengsch,德国大学,HCV/HIV 双重感染)和印度(V. Ramachandran 和 K. Murugarel、HIV 感染和粘膜免疫)。这些积极的互动继续为埃默里大学和受训者家庭实验室的研究人员之间的合作创造未来的机会。
CFAR 临床前病毒学核心也位于耶基斯疫苗中心,为埃默里大学和其他机构的研究人员提供有价值的检测服务。除了长期以来进行的病毒载量测定之外,该单位现在还提供该核心在过去一年开发的一系列基因表达测定。最后,病毒学核心为那些想要进行自己的检测的研究人员提供培训,并为这些研究人员提供其高科技检测设备。
通过战略性使用 GRA 资金,CFAR 能够留住关键教职人员,招募初级教职人员,并为许多核心提供必要的设备,包括免疫学、病毒学和药物发现以及临床研究核心。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES W. CURRAN其他文献
JAMES W. CURRAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES W. CURRAN', 18)}}的其他基金
Predicting the Effect of Testing For and Treating HIV in Correctional Facilities
预测惩教设施中艾滋病毒检测和治疗的效果
- 批准号:
8134701 - 财政年份:2010
- 资助金额:
$ 13.16万 - 项目类别:
Infant Immunization to Reduce Pneumonia in HIV +ve women
婴儿免疫接种可减少艾滋病毒 ve 妇女的肺炎
- 批准号:
6778684 - 财政年份:2002
- 资助金额:
$ 13.16万 - 项目类别:
相似国自然基金
从CD4+、CD8+T细胞免疫活化分子及其上游调控因子表达探究健脾祛湿法治疗艾滋病免疫调节机制
- 批准号:81460716
- 批准年份:2014
- 资助金额:48.0 万元
- 项目类别:地区科学基金项目
HAART过程中HCV复制增强与肝细胞MAVS抗病毒通路的关系研究
- 批准号:81201286
- 批准年份:2012
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM)Research Core - Methods
迈阿密大学艾滋病心理健康和艾滋病毒/艾滋病研究中心 - Center for HIV
- 批准号:
10686544 - 财政年份:2023
- 资助金额:
$ 13.16万 - 项目类别:
Neurofunctional Mechanisms of Changes in Cognition and Motor Function in Aging with HIV and Parkinson's Disease
HIV 和帕金森病导致的衰老过程中认知和运动功能变化的神经功能机制
- 批准号:
10619383 - 财政年份:2023
- 资助金额:
$ 13.16万 - 项目类别:
Therapeutic and mechanistic significance of altered metabolism of HIV medicines by alcohol- or alcohol/synthetic opioid combination
酒精或酒精/合成阿片类药物组合改变 HIV 药物代谢的治疗和机制意义
- 批准号:
10542286 - 财政年份:2022
- 资助金额:
$ 13.16万 - 项目类别:
Children's National Hospital Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
国家儿童医院基地联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
- 批准号:
10599559 - 财政年份:2022
- 资助金额:
$ 13.16万 - 项目类别:
A mixed methods approach to address multi-level barriers to care for migratory men living with HIV in South Africa
采用混合方法解决照顾南非艾滋病毒携带者移民男性的多层次障碍
- 批准号:
10403224 - 财政年份:2022
- 资助金额:
$ 13.16万 - 项目类别: